BMY

Bristol-Myers Squibb

Halal Rating :
Comfortable
See Details
Last Price $43.98 Last updated:
Market Cap $90.49b
7D Change -3.47%
1 Year Change -25.41%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NYSE
Next Earnings Date Feb. 2, 2024

Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $11.87b $15.73b - $425.0m 0.00% 2.70%
Dec. 31, 2023 $11.48b $14.44b - $316.0m 0.00% 2.19%
Sept. 30, 2023 $10.97b $13.82b $173.0m $280.0m 1.58% 2.03%

Company Impact

Help us evaluate Bristol-Myers Squibb's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates